By Kat Greene ( February 29, 2016, 7:31 PM EST) -- Valeant Pharmaceuticals International Inc. is under investigation by the U.S. Securities and Exchange Commission, the company said Monday, shortly after announcing its CEO's return from medical leave, a generic-drug maker's challenge to one of its drugs, and that it would have to restate earnings....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.